HomeClinical TopicsFDA approves Brintellix for major depression

FDA approves Brintellix for major depression

Author(s):

On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Brintellix (vortioxetine) to treat adults with major depressive disorder. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content